Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Telix Pharmaceuticals Limited (TLX) Shareholders To Inquire About Securities Fraud Class Action
Telix Pharmaceuticals LtdTelix Pharmaceuticals Ltd(US:TLX) Businesswire·2025-11-13 18:15

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Limited ("Telix†or the "Company†) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive (the "Class Period†). Telix investors have until January 9, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS. ...